An ocean of possibilities: a review of marine organisms as sources of nanoparticles for cancer care

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Roma-Rodrigues C, Rivas-García L, Baptista P V, Fernandes AR. Gene therapy in cancer treatment: why go nano? Pharmaceutics 12(3), 233 (2020).
  Medline CASGoogle Scholar
• 2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394–424 (2018).
  MedlineGoogle Scholar
• 3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 70(1), 7–30 (2020).
  MedlineGoogle Scholar
• 4. Chizenga EP, Abrahamse H. Nanotechnology in modern photodynamic therapy of cancer: a review of cellular resistance patterns affecting the therapeutic response. Pharmaceutics 12(7), 623 (2020).
  MedlineGoogle Scholar
• 5. Pereira RB, Evdokimov NM, Lefranc F et al. Marine-derived anticancer agents: clinical benefits, innovative mechanisms, and new targets. Mar. Drugs 17(6), 329 (2019).
  Medline CASGoogle Scholar
• 6. Dayanidhi DL, Thomas BC, Osterberg JS et al. Exploring the diversity of the marine environment for new anti-cancer compounds. Front. Mar. Sci. 7, 1184 (2021).
  Google Scholar
• 7. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100(1–2), 72–79 (2005).
  Medline CASGoogle Scholar
• 8. Michalak I, Püsküllüoğlu M. Look into my onco-forest–review of plant natural products with anticancer activity. Curr. Top. Med. Chem. 22(11), 922–938 (2022).
  MedlineGoogle Scholar
• 9. Asmathunisha N, Kathiresan K. A review on biosynthesis of nanoparticles by marine organisms. Colloids Surf. B. Biointerfaces 103, 283–287 (2013). •• A review covering the biosynthesis of marine-derived nanoparticles (NPs) and organisms acting as NP sources.
  Medline CASGoogle Scholar
• 10. Saeed A, Su J, Ouyang S. Marine-derived drugs: recent advances in cancer therapy and immune signaling. Biomed. Pharmacother. 134, 111091 (2021).
  Medline CASGoogle Scholar
• 11. Jaspars M, De Pascale D, Andersen JH, Reyes F, Crawford AD, Ianora A. The marine biodiscovery pipeline and ocean medicines of tomorrow. J. Mar. Biol. Assoc. UK 96(1), 151–158 (2016).
  Google Scholar
• 12. Arjunan N, Kumari HLJ, Singaravelu CM, Kandasamy R, Kandasamy J. Physicochemical investigations of biogenic chitosan-silver nanocomposite as antimicrobial and anticancer agent. Int. J. Biol. Macromol. 92, 77–87 (2016).
  Medline CASGoogle Scholar
• 13. Chen X, Han W, Zhao X, Tang W, Wang F. Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release. Sci. Rep. 9(1), 6754 (2019).
  MedlineGoogle Scholar
• 14. Chen T, Wong Y-S, Zheng W, Bai Y, Huang L. Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells. Colloids Surf. B. Biointerfaces 67(1), 26–31 (2008).
  Medline CASGoogle Scholar
• 15. Khavari F, Saidijam M, Taheri M, Nouri F. Microalgae: therapeutic potentials and applications. Mol. Biol. Rep. 48(5), 4757–4765 (2021).
  Medline CASGoogle Scholar
• 16. Hua S, de Matos MBC, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Front. Pharmacol. 9, 790 (2018). •• A review describing the broad role of nanoparticles in medical fields.
  MedlineGoogle Scholar
• 17. Ren X, Xie X, Chen B, Liu L, Jiang C, Qian Q. Marine natural products: a potential source of anti-hepatocellular carcinoma drugs. J. Med. Chem. 64(12), 7879–7899 (2021).
  Medline CASGoogle Scholar
• 18. Jimenez PC, Wilke DV, Branco PC et al. Enriching cancer pharmacology with drugs of marine origin. Br. J. Pharmacol. 177(1), 3–27 (2020).
  Medline CASGoogle Scholar
• 19. Wu L, Ye K, Jiang S, Zhou G. Marine power on cancer: drugs, lead compounds, and mechanisms. Mar. Drugs 19(9), 488(2021).
  Medline CASGoogle Scholar
• 20. Sekar P, Ravitchandirane R, Khanam S, Muniraj N, Cassinadane AV. Novel molecules as the emerging trends in cancer treatment: an update. Med. Oncol. 39(2), 20 (2022).
  Medline CASGoogle Scholar
• 21. Faruqi A, Tadi P. Cytarabine. StatPearls Publishing, Treasure Island (FL) (2022).
  Google Scholar
• 22. Larsen AK, Galmarini CM, D'Incalci M. Unique features of trabectedin mechanism of action. Cancer Chemother. Pharmacol. 77(4), 663–671 (2016).
  Medline CASGoogle Scholar
• 23. Shetty N, Gupta S. Eribulin drug review. South Asian J. Cancer 3(1), 57–59 (2014).
  MedlineGoogle Scholar
• 24. Tong JTW, Harris PWR, Brimble MA, Kavianinia I. An insight into FDA approved antibody-drug conjugates for cancer therapy. Molecules 26(19), 5847 (2021).
  Medline CASGoogle Scholar
• 25. Hafeez U, Parakh S, Gan HK, Scott AM. Antibody–drug conjugates for cancer therapy. Molecules 25(20), 4764 (2020).
  Medline CASGoogle Scholar
• 26. Cardoso MJ, Costa RR, Mano JF. Marine origin polysaccharides in drug delivery systems. Mar. Drugs 14(2), 34 (2016).
  MedlineGoogle Scholar
• 27. Korbelik M, Hode T, Lam SSK, Chen WR. Novel immune stimulant amplifies direct tumoricidal effect of cancer ablation therapies and their systemic antitumor immune efficacy. Cells 10(3), 492 (2021).
  Medline CASGoogle Scholar
• 28. Dyshlovoy SA. Recent updates on marine cancer-preventive compounds. Mar. Drugs 19(10), 558 (2021).
  Medline CASGoogle Scholar
• 29. Correia-da-Silva M, Sousa E, Pinto MMM, Kijjoa A. Anticancer and cancer preventive compounds from edible marine organisms. Semin. Cancer Biol. 46, 55–64 (2017).
  Medline CASGoogle Scholar
• 30. Asmathunisha N, Kathiresan K. A review on biosynthesis of nanoparticles by marine organisms. Colloids Surf. B. Biointerfaces 103, 283–287 (2013).
  Medline CASGoogle Scholar
• 31. Chugh D, Viswamalya VS, Das B. Green synthesis of silver nanoparticles with algae and the importance of capping agents in the process. J. Genet. Eng. Biotechnol. 19(1), 126 (2021).
  MedlineGoogle Scholar
• 32. Tian S, Saravanan K, Mothana RA, Ramachandran G, Rajivgandhi G, Manoharan N. Anti-cancer activity of biosynthesized silver nanoparticles using Avicennia marina against A549 lung cancer cells through ROS/mitochondrial damages. Saudi J. Biol. Sci. 27(11), 3018 (2020).
  Medline CASGoogle Scholar
• 33. González-Ballesteros N, Rodríguez-Argüelles MC, Lastra-Valdor M. Evaluation of the antioxidant capacities of Antarctic macroalgae and their use for nanoparticles production. Molecules 26(4), 1182 (2021). •• Research describing the process of obtaining nanoparticles from macroalgae.
  Medline CASGoogle Scholar
• 34. Omar HH, Bahabri FS, El-Gendy AM. Biopotential application of synthesis nanoparticles as antimicrobial agents by using Laurencia papillosa. Int. J. Pharmacol. 13(3), 303–312 (2017).
  CASGoogle Scholar
• 35. Khanna P, Kaur A, Goyal D. Algae-based metallic nanoparticles: synthesis, characterization and applications. J. Microbiol. Methods 163(June), 105656 (2019).
  Medline CASGoogle Scholar
• 36. Michalak I, Chojnacka K. Algae as production systems of bioactive compounds. Eng. Life Sci. 15(2), 160–176 (2015).
  CASGoogle Scholar
• 37. Manivasagan P, Oh J. Marine polysaccharide-based nanomaterials as a novel source of nanobiotechnological applications. Int. J. Biol. Macromol. 82, 315–327 (2016).
  Medline CASGoogle Scholar
• 38. Palanisamy S, Vinosha M, Marudhupandi T, Rajasekar P, Prabhu NM. Isolation of fucoidan from Sargassum polycystum brown algae: structural characterization, in vitro antioxidant and anticancer activity. Int. J. Biol. Macromol. 102, 405–412 (2017).
  Medline CASGoogle Scholar
• 39. Viswanathan S, Palaniyandi T, Shanmugam R, M T, Rajendran BK, Sivaji A. Biomedical potential of silver nanoparticles capped with active ingredients of Hypnea valentiae, red algae species. Part. Sci. Technol. 1–11 (2021).
  Google Scholar
• 40. Jacob RH, Shanab SM, Shalaby EA. Algal biomass nanoparticles: chemical characteristics, biological actions, and applications. Biomass Convers. Biorefin. 23, 1–15, (2021).
  Google Scholar
• 41. Devi JS, Bhimba BV. Anticancer activity of silver nanoparticles synthesized by the seaweed Ulva Iactuca in vitro. Sci. Rep. 1, 242 (2012).
  Google Scholar
• 42. Zhang D, Ramachandran G, Mothana RA et al. Biosynthesized silver nanoparticles using Caulerpa taxifolia against A549 lung cancer cell line through cytotoxicity effect/morphological damage. Saudi J. Biol. Sci. 27(12), 3421–3427 (2020).
  Medline CASGoogle Scholar
• 43. Namvar F, Rahman HS, Mohamad R et al. Cytotoxic effect of magnetic iron oxide nanoparticles synthesized via seaweed aqueous extract. Int. J. Nanomed. 9, 2479–2488 (2014). •• Research describing the cytotoxic effects of marine particles.
  MedlineGoogle Scholar
• 44. Rocha Amorim MO, Lopes Gomes D, Dantas LA et al. Fucan-coated silver nanoparticles synthesized by a green method induce human renal adenocarcinoma cell death. Int. J. Biol. Macromol. 93(Pt A), 57–65 (2016).
  MedlineGoogle Scholar
• 45. Etman SM, Abdallah OY, Elnaggar YSR. Novel fucoidan-based bioactive targeted nanoparticles from Undaria pinnatifida for treatment of pancreatic cancer. Int. J. Biol. Macromol. 145, 390–401 (2020).
  Medline CASGoogle Scholar
• 46. Etman SM, Mehanna RA, Bary AA, Elnaggar YSR, Abdallah OY. Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer. Int. J. Biol. Macromol. 170, 284–297 (2021).
  Medline CASGoogle Scholar
• 47. Yosri N, Khalifa SAM, Guo Z, Xu B, Zou X, El-Seedi HR. Marine organisms: pioneer natural sources of polysaccharides/proteins for green synthesis of nanoparticles and their potential applications. Int. J. Biol. Macromol. 193(Pt B), 1767–1798 (2021).
  Medline CASGoogle Scholar
• 48. Chanthini AB, Balasubramani G, Ramkumar R et al. Structural characterization, antioxidant and in vitro cytotoxic properties of seagrass, Cymodocea serrulata (R.Br.) Asch. & Magnus mediated silver nanoparticles. J. Photochem. Photobiol. B Biol. 153, 145–152 (2015).
  Medline CASGoogle Scholar
• 49. Palaniappan P, Sathishkumar G, Sankar R. Fabrication of nano-silver particles using Cymodocea serrulata and its cytotoxicity effect against human lung cancer A549 cells line. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 138, 885–890 (2015).
  Medline CASGoogle Scholar
• 50. Eswaraiah G, Peele KA, Krupanidhi S, Kumar RB, Venkateswarulu TC. Identification of bioactive compounds in leaf extract of Avicennia alba by GC-MS analysis and evaluation of its in vitro anticancer potential against MCF7 and HeLa cell lines. J. King Saudi Univ. Sci. 32(1), 740–744 (2020).
  Google Scholar
• 51. Bajpai V, Shukla S, Kang S-M et al. Developments of cyanobacteria for nano-marine drugs: relevance of nanoformulations in cancer therapies. Mar. Drugs 16(6), 179 (2018).
  MedlineGoogle Scholar
• 52. Todd T, Zhen Z, Tang W et al. Iron oxide nanoparticle encapsulated diatoms for magnetic delivery of small molecules to tumors. Nanoscale 6(4), 2073–2076 (2014).
  Medline CASGoogle Scholar
• 53. Sathishkumar RS, Sundaramanickam A, Srinath R et al. Green synthesis of silver nanoparticles by bloom-forming marine microalgae Trichodesmium erythraeum and its applications in antioxidant, drug-resistant bacteria, and cytotoxicity activity. J. Saudi Chem. Soc. 23(8), 1180–1191 (2019).
  CASGoogle Scholar
• 54. Hassabo AA, Ibrahim E, Ali B, Emam HE. Anticancer effects of biosynthesized Cu₂O nanoparticles using marine yeast. Biocatal. Agric. Biotechnol. 39, 102261 (2022).
  CASGoogle Scholar
• 55. Anand BG, Thomas CKN, Prakash S, Kumar CS. Biosynthesis of silver nanoparticles by marine sediment fungi for a dose-dependent cytotoxicity against Hep2 cell lines. Biocatal. Agric. Biotechnol. 4(2), 150–157 (2015). • Research describing the process of obtaining nanoparticles from marine fungi.
  Google Scholar
• 56. Subhapradha N, Shanmugam V, Shanmugam A. Chitosan nanoparticles from marine squid protect liver cells against N-diethylnitrosoamine-induced hepatocellular carcinoma. Carbohydr. Polym. 171, 18–26 (2017).
  Medline CASGoogle Scholar
• 57. Subhapradha N, Shanmugam A. Fabrication of β-chitosan nanoparticles and its anticancer potential against human hepatoma cells. Int. J. Biol. Macromol. 94(Pt A), 194–201 (2017).
  Medline CASGoogle Scholar
• 58. Subhapradha N, Ramasamy P, Shanmugam V, Madeswaran P, Srinivasan A, Shanmugam A. Physicochemical characterisation of β-chitosan from Sepioteuthis lessoniana gladius. Food Chem. 141(2), 907–913 (2013).
  Medline CASGoogle Scholar
• 59. Smitha KT, Anitha A, Furuike T, Tamura H, Nair S V, Jayakumar R. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery. Colloids Surf. B. Biointerfaces 104, 245–253 (2013).
  Medline CASGoogle Scholar
• 60. Inbakandan D, Kumar C, Bavanilatha M, Ravindra DN, Kirubagaran R, Khan SA. Ultrasonic-assisted green synthesis of flower like silver nanocolloids using marine sponge extract and its effect on oral biofilm bacteria and oral cancer cell lines. Microb. Pathog. 99, 135–141 (2016).
  Medline CASGoogle Scholar
• 61. Al-Khalaf AA, Hassan HM, Alrajhi AM, Mohamed RAEH, Hozzein WN. Anti-cancer and anti-inflammatory potential of the green synthesized silver nanoparticles of the red sea sponge phyllospongia lamellosa supported by metabolomics analysis and docking study. Antibiotics 10(10), 1155 (2021).
  CASGoogle Scholar
• 62. González-Ballesteros N, Prado-López S, Rodríguez-González JB, Lastra M, Rodríguez-Argüelles MC. Green synthesis of gold nanoparticles using brown algae Cystoseira baccata: its activity in colon cancer cells. Colloids Surf. B. Biointerfaces 153, 190–198 (2017).
  Medline CASGoogle Scholar
• 63. Venkatesan J, Kim S-K, Shim MS. Antimicrobial, antioxidant, and anticancer activities of biosynthesized silver nanoparticles using marine algae Ecklonia cava. Nanomater. (Basel) 6(12), 235 (2016).
  MedlineGoogle Scholar
• 64. Shunmugam R, Renukadevi Balusamy S, Kumar V, Menon S, Lakshmi T, Perumalsamy H. Biosynthesis of gold nanoparticles using marine microbe (Vibrio alginolyticus) and its anticancer and antioxidant analysis. J. King Saudi Univ. Sci. 33(1), 101260 (2021).
  Google Scholar
• 65. Vieira AP, Stein EM, Andreguetti DX, Colepicolo P, da Costa Ferreira AM. Preparation of silver nanoparticles using aqueous extracts of the red algae Laurencia aldingensis and Laurenciella sp. and their cytotoxic activities. J. Appl. Phycol. 28(4), 2615–2622 (2016).
  Google Scholar
• 66. Venkatesan T, Choi Y-W, Mun S-P, Kim Y-K. Pinus radiata bark extract induces caspase-independent apoptosis-like cell death in MCF-7 human breast cancer cells. Cell Biol. Toxicol. 32(5), 451–464 (2016).
  MedlineGoogle Scholar
• 67. Jeyarani S, Vinita NM, Puja P et al. Biomimetic gold nanoparticles for its cytotoxicity and biocompatibility evidenced by fluorescence-based assays in cancer (MDA-MB-231) and non-cancerous (HEK-293) cells. J. Photochem. Photobiol. B Biol. 202, 111715 (2020).
  Medline CASGoogle Scholar
• 68. Trindade T, Lusa A. Biofunctional composites of polysaccharides containing inorganic nanoparticles. In: Advances in Nanocomposite Technology. IntechOpen, London, UK (2011).
  Google Scholar
• 69. Oliveira C, Neves NM, Reis RL, Martins A, Silva TH. Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells. Nanomedicine (London) 13(16), 2037–2050 (2018).
  CASGoogle Scholar
• 70. Rajeshkumar S. Phytochemical constituents of fucoidan (Padina tetrastromatica) and its assisted AgNPs for enhanced antibacterial activity. IET Nanobiotechnol. 11(3), 292–299 (2017).
  Medline CASGoogle Scholar
• 71. Indra Priyadharshini R, Prasannaraj G, Geetha N et al. Microwave-mediated extracellular synthesis of metallic silver and zinc oxide nanoparticles using macro-algae (Gracilaria edulis) extracts and its anticancer activity against human PC3 cell lines. Appl. Biochem. Biotechnol. 174, 2777–2790 (2014).
  MedlineGoogle Scholar
• 72. Gopu M, Kumar P, Selvankumar T et al. Green biomimetic silver nanoparticles utilizing the red algae Amphiroa rigida and its potent antibacterial, cytotoxicity and larvicidal efficiency. Bioprocess Biosyst. Eng. 44(2), 217–223 (2021).
  Medline CASGoogle Scholar
• 73. Rajeshkumar S, Malarkodi C, Vanaja M, Annadurai G. Anticancer and enhanced antimicrobial activity of biosynthesized silver nanoparticles against clinical pathogens. J. Mol. Struct. 1116, 165–173 (2016).
  CASGoogle Scholar
• 74. Shankar PD, Shobana S, Karuppusamy I et al. A review on the biosynthesis of metallic nanoparticles (gold and silver) using bio-components of microalgae: formation mechanism and applications. Enzyme Microb. Technol. 95, 28–44 (2016).
  Medline CASGoogle Scholar
• 75. Rajeshkumar S. Anticancer activity of eco-friendly gold nanoparticles against lung and liver cancer cells. J. Genet. Eng. Biotechnol. 14(1), 195–202 (2016).
  Medline CASGoogle Scholar
• 76. Remya RR, Radhika Rajasree SR, Aranganathan L, Suman TY, Gayathri S. Enhanced cytotoxic activity of AgNPs on retinoblastoma Y79 cell lines synthesised using marine seaweed Turbinaria ornata. IET Nanobiotechnol. 11(1), 18–23 (2017).
  MedlineGoogle Scholar
• 77. Li X, Xu H, Chen Z-S, Chen G. Biosynthesis of nanoparticles by microorganisms and their applications. J. Nanomater. 2011, 1–16 (2011).
  MedlineGoogle Scholar
• 78. Venkatpurwar V, Mali V, Bodhankar S, Pokharkar V. In vitro cytotoxicity and in vivo sub-acute oral toxicity assessment of porphyran reduced gold nanoparticles. Toxicol. Environ. Chem. 94(7), 1357–1367 (2012).
  CASGoogle Scholar
• 79. Pawar VK, Singh Y, Sharma K et al. Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin. Int. J. Biol. Macromol. 122, 1100–1114 (2019).
  Medline CASGoogle Scholar
• 80. Shamay Y, Elkabets M, Li H et al. P-selectin is a nanotherapeutic delivery target in the tumor microenvironment. 8(345), 345ra87 (2016).
  Google Scholar
• 81. Selvi BCG, Madhavan J, Santhanam A, Gnana Selvi BC, Madhavan J, Santhanam A. Cytotoxic effect of silver nanoparticles synthesized from Padina tetrastromatica on breast cancer cell line. Adv. Nat. Sci. Nanosci. Nanotechnol. 7(3), 035015 (2016).
  Google Scholar
• 82. Valarmathi N, Ameen F, Almansob A, Kumar P, Arunprakash S, Govarthanan M. Utilization of marine seaweed Spyridia filamentosa for silver nanoparticles synthesis and its clinical applications. Mater. Lett. 263, 127244 (2020).
  CASGoogle Scholar
• 83. Lu K-Y, Li R, Hsu C-H et al. Development of a new type of multifunctional fucoidan-based nanoparticles for anticancer drug delivery. Carbohydr. Polym. 165, 410–420 (2017).
  Medline CASGoogle Scholar
• 84. Lee KW, Jeong D, Na K. Doxorubicin loading fucoidan acetate nanoparticles for immune and chemotherapy in cancer treatment. Carbohydr. Polym. 94(2), 850–856 (2013).
  Medline CASGoogle Scholar
• 85. Al-Malki AL. In vitro cytotoxicity and pro-apoptotic activity of phycocyanin nanoparticles from Ulva lactuca (Chlorophyta) algae. Saudi J. Biol. Sci. 27(3), 894–898 (2020).
  Medline CASGoogle Scholar
• 86. Rajeshkumar S, Kumar SV, Malarkodi C, Vanaja M, Paulkumar K, Annadurai G. Optimized synthesis of gold nanoparticles using green chemical process and its in vitro anticancer activity against HepG2. Mech. Mater. Sci. Eng. (March), 1–6 (2017).
  Google Scholar
• 87. Sutradhar KB, Amin ML. Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanotechnol. 2014, 1–12 (2014).
  Google Scholar
• 88. Barbosa AI, Coutinho AJ, Costa Lima SA, Reis S. Marine polysaccharides in pharmaceutical applications: fucoidan and chitosan as key players in the drug delivery match field. Mar. Drugs 17(12), 654 (2019).
  Medline CASGoogle Scholar
• 89. Pasut G. Grand challenges in nano-based drug delivery. Front. Med. Technol. 1, 1 (2019).
  MedlineGoogle Scholar
• 90. Yao Y, Zhou Y, Liu L et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front. Mol. Biosci. 7, 193 (2020).
  Medline CASGoogle Scholar
• 91. Liu Z, Lv D, Liu S et al. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice. PLOS ONE 8(4), e60190 (2013).
  Medline CASGoogle Scholar
• 92. Fedorov SN, Ermakova SP, Zvyagintseva TN, Stonik VA. Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects. Mar. Drugs 11(12), 4876–4901 (2013).
  Medline CASGoogle Scholar
• 93. Oliveira C, Granja S, Neves NM et al. Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo. Carbohydr. Polym. 223, 115034 (2019).
  Medline CASGoogle Scholar
• 94. Subbaiya R, Saravanan M, Priya AR et al. Biomimetic synthesis of silver nanoparticles from Streptomyces atrovirens and their potential anticancer activity against human breast cancer cells. IET Nanobiotechnol. 11(8), 965–972 (2017).
  MedlineGoogle Scholar
• 95. Kim H, Nguyen VP, Manivasagan P et al. Doxorubicin-fucoidan-gold nanoparticles composite for dual-chemo-photothermal treatment on eye tumors. Oncotarget 8(69), 113719–113733 (2017).
  MedlineGoogle Scholar
• 96. Desai P, Thumma NJ, Wagh PR et al. Cancer chemoprevention using nanotechnology-based approaches. Front. Pharmacol. 11, 323 (2020).
  Medline CASGoogle Scholar
• 97. Wu S-Y, Parasuraman V, Hsieh-Chih-Tsai H-C-T et al. Radioprotective effect of self-assembled low molecular weight fucoidan-chitosan nanoparticles. Int. J. Pharm. 579, 119161 (2020).
  Medline CASGoogle Scholar
• 98. Jiang Z, Okimura T, Yokose T, Yamasaki Y, Yamaguchi K, Oda T. Effects of sulfated fucan, ascophyllan, from the brown Alga Ascophyllum nodosum on various cell lines: a comparative study on ascophyllan and fucoidan. J. Biosci. Bioeng. 110(1), 113–117 (2010).
  Medline CASGoogle Scholar
• 99. Vishchuk OS, Ermakova SP, Zvyagintseva TN. Sulfated polysaccharides from brown seaweeds Saccharina japonica and Undaria pinnatifida: isolation, structural characteristics, and antitumor activity. Carbohydr. Res. 346(17), 2769–2776 (2011).
  Medline CASGoogle Scholar
• 100. Yang M, Ma C, Sun J et al. Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells. Int. Immunopharmacol. 8(13–14), 1754–1760 (2008).
  Medline CASGoogle Scholar
• 101. Kuznetsova TA, Smolina TP, Makarenkova ID et al. Immunoadjuvant activity of fucoidans from the brown alga Fucus evanescens. Mar. Drugs 18(3), 155 (2020).
  Medline CASGoogle Scholar
• 102. Chandrarathna HPSU, Liyanage TD, Edirisinghe SL et al. Marine microalgae, Spirulina maxima-derived modified pectin and modified pectin nanoparticles modulate the gut microbiota and trigger immune responses in mice. Mar. Drugs 18(3), 175 (2020).
  Medline CASGoogle Scholar
• 103. Dai Z, Zhang J, Wu Q et al. Intestinal microbiota: a new force in cancer immunotherapy. Cell Commun. Signal. 18(1), 90 (2020).
  MedlineGoogle Scholar
• 104. Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg. 8(1), 34 (2021).
  Medline CASGoogle Scholar
• 105. Kalra J, Krishna V, Reddy BSV, Dhar A, Venuganti VVK, Bhat A. Nanoparticles in medical imaging. Nanoparticles Anal. Med. Devices 175–210 (2021).
  Google Scholar
• 106. Andreou C, Pal S, Rotter L, Yang J, Kircher MF. Molecular imaging in nanotechnology and theranostics. Mol. Imaging Biol. 19(3), 363–372 (2017).
  MedlineGoogle Scholar
• 107. Baetke SC, Lammers T, Kiessling F. Applications of nanoparticles for diagnosis and therapy of cancer. Br. J. Radiol. 88(1054), 20150207 (2015).
  Medline CASGoogle Scholar
• 108. Truini A, Alama A, Dal Bello MG et al. Clinical applications of circulating tumor cells in lung cancer patients by CellSearch system. Front. Oncol. 4, 242 (2014).
  MedlineGoogle Scholar
• 109. Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur. J. Pharm. Biopharm. 93, 52–79 (2015).
  Medline CASGoogle Scholar
• 110. Senapati D, Patra BC, Kar A et al. Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy. Gene 719, 144071 (2019).
  Medline CASGoogle Scholar
• 111. Tan ML, Choong PFM, Dass CR. Cancer, chitosan nanoparticles and catalytic nucleic acids. J. Pharm. Pharmacol. 61(1), 3–12 (2010).
  Google Scholar
• 112. Amreddy N, Babu A, Muralidharan R et al. Recent advances in nanoparticle-based cancer drug and gene delivery. Adv. Cancer Res. 137, 115 (2018).
  Medline CASGoogle Scholar
• 113. Acharya D, Satapathy S, Thathapudi JJ, Somu P, Mishra G. Biogenic synthesis of silver nanoparticles using marine algae Cladophora glomerata and evaluation of apoptotic effects in human colon cancer cells. Mater. Technol. 37(8), 569–580 (2020).
  Google Scholar
• 114. Zhang Z, Teruya K, Eto H, Shirahata S. Fucoidan extract induces apoptosis in MCF-7 cells via a mechanism involving the ROS-dependent JNK activation and mitochondria-mediated pathways. PLOS ONE 6(11), e27441 (2011).
  Medline CASGoogle Scholar
• 115. Acharya D, Satapathy S, Somu P, Parida UK, Mishra G. Apoptotic effect and anticancer activity of biosynthesized silver nanoparticles from marine algae Chaetomorpha linum extract against human colon cancer cell HCT-116. Biol. Trace Elem. Res. 199(5), 1812–1822 (2021).
  Medline CASGoogle Scholar
• 116. Chiang CS, Huang BJ, Chen JY et al. Fucoidan-based nanoparticles with inherently therapeutic efficacy for cancer treatment. Pharmaceutics 13(12), 1986 (2021).
  Medline CASGoogle Scholar
• 117. Ahn E-Y, Hwang SJ, Choi M-J, Cho S, Lee H-J, Park Y. Upcycling of jellyfish (Nemopilema nomurai) sea wastes as highly valuable reducing agents for green synthesis of gold nanoparticles and their antitumor and anti-inflammatory activity. Artif. Cells Nanomed. Biotechnol. 46(Suppl. 2), 1127–1136 (2018).
  Medline CASGoogle Scholar
• 118. Narazaki M, Segarra M, Tosato G. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood 111(8), 4126–4136 (2008).
  Medline CASGoogle Scholar
• 119. Sanaeimehr Z, Javadi I, Namvar F. Antiangiogenic and antiapoptotic effects of green-synthesized zinc oxide nanoparticles using Sargassum muticum algae extraction. Cancer Nanotechnol. 9(1), 3 (2018). • An example of research describing the antiangiogenic and antiapoptotic effects of marine particles.
  MedlineGoogle Scholar
• 120. Liu JM, Bignon J, Haroun-Bouhedja F et al. Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin. Anticancer Res. 25(3B), 2129–2133 (2005).
  Medline CASGoogle Scholar
• 121. Adhikari HS, Yadav PN. Anticancer activity of chitosan, chitosan derivatives, and their mechanism of action. Int. J. Biomater. 2018, 2952085 (2018).
  MedlineGoogle Scholar
• 122. Zolnik BS, González-Fernández A, Sadrieh N, Dobrovolskaia MA. Nanoparticles and the immune system. Endocrinology 151(2), 458–465 (2010).
  Medline CASGoogle Scholar
• 123. González-Ballesteros N, Diego-González L, Lastra-Valdor M et al. Immunomodulatory and antitumoral activity of gold nanoparticles synthesized by red algae aqueous extracts. Mar. Drugs 20(3), 182 (2022).
  Medline CASGoogle Scholar
• 124. Alavi M, Hamidi M. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metab. Pers. Ther. 34(1), 20180032 (2019).
  Google Scholar
• 125. Kim B, Park J-E, Im E et al. Recent advances in nanotechnology with nano-phytochemicals: molecular mechanisms and clinical implications in cancer progression. Int. J. Mol. Sci. 22(7), 3571 (2021). •• A review covering molecular pathways through which NPs influence cancer progression.
  Medline CASGoogle Scholar
• 126. Katuwavila NP, Perera ADLC, Samarakoon SR et al. Chitosan-alginate nanoparticle system efficiently delivers doxorubicin to MCF-7 cells. J. Nanomater. 2016, 1–12 (2016). • An example of research showing marine NPs as drug-delivery systems.
  Google Scholar
• 127. Sultan MH, Moni SS, Madkhali OA et al. Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer. Sci. Rep. 12(1), 468 (2022).
  Medline CASGoogle Scholar
• 128. Arias JL, Reddy LH, Couvreur P. Fe₃O₄/chitosan nanocomposite for magnetic drug targeting to cancer. J. Mater. Chem. 22(15), 7622 (2012).
  CASGoogle Scholar
• 129. Anirudhan TS, Sekhar VC, Nair SS. Polyelectrolyte complexes of carboxymethyl chitosan/alginate based drug carrier for targeted and controlled release of dual drug. J. Drug Deliv. Sci. Technol. 51, 569–582 (2019).
  CASGoogle Scholar
• 130. Parsian M, Unsoy G, Mutlu P, Yalcin S, Tezcaner A, Gunduz U. Loading of gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug. Eur. J. Pharmacol. 784, 121–128 (2016).
  Medline CASGoogle Scholar
• 131. Conde J, Oliva N, Zhang Y, Artzi N. Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat. Mater. 15(10), 1128–1138 (2016).
  Medline CASGoogle Scholar
• 132. Pietersz GA, Wang X, Yap ML, Lim B, Peter K. Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies. Nanomedicine 12(15), 1873–1889 (2017).
  CASGoogle Scholar
• 133. Kodet O, Němejcova K, Strnadová K et al. The abscopal effect in the era of checkpoint inhibitors. Int. J. Mol. Sci. 22(13), 7204 (2021).
  Medline CASGoogle Scholar
• 134. Pevzner AM, Tsyganov MM, Ibragimova MK, Litvyakov NV. Abscopal effect in the radio and immunotherapy. Radiat. Oncol. J. 39(4), 247–253 (2021).
  MedlineGoogle Scholar
• 135. Jang B, Moorthy MS, Manivasagan P et al. Fucoidan-coated CuS nanoparticles for chemo- and photothermal therapy against cancer. Oncotarget 9(16), 12649–12661 (2018).
  MedlineGoogle Scholar